Review
Published on 01 May 2023
Molecular mechanisms of osteosarcoma metastasis and possible treatment opportunities
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1117867
- 5,564 views
- 6 citations
Type at least 3 characters
2,922 articles
Articles
Review
Published on 01 May 2023
Quantitative proteomic studies addressing unmet clinical needs in sarcoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1126736
- 3,450 views
- 2 citations
Review
Published on 01 May 2023
The promise and challenge of spatial omics in dissecting tumour microenvironment and the role of AI
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1172314
- 9,382 views
- 7 citations
Original Research
Published on 28 Apr 2023
Formulation and validation of a baseline prognostic score for osteosarcoma treated uniformly with a non-high dose methotrexate-based protocol from a low middle income healthcare setting: a single centre analysis of 594 patients
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1148480
- 1,490 views
- 1 citation
Original Research
Published on 28 Apr 2023
Chitinase-like proteins promoting tumorigenesis through disruption of cell polarity via enlarged endosomal vesicles
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1170122
- 1,582 views
- 2 citations
Review
Published on 28 Apr 2023
The emerging role of neutrophil extracellular traps in cancer: from lab to ward
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1163802
- 4,630 views
- 7 citations
Review
Published on 28 Apr 2023
Tumor heterogeneity: preclinical models, emerging technologies, and future applications
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1164535
- 10,809 views
- 27 citations
Original Research
Published on 27 Apr 2023
Bibliometric analysis of ferroptosis: a comprehensive evaluation of its contribution to cancer immunity and immunotherapy
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1183405
- 2,648 views
- 1 citation
Review
Published on 27 Apr 2023
Multiple functions and regulatory network of miR-150 in B lymphocyte-related diseases
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1140813
- 2,195 views
- 9 citations
Mini Review
Published on 27 Apr 2023
An anti-cancer surveillance by the interplay between interferon-beta and retinoblastoma protein RB1
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1173467
- 2,279 views
- 8 citations
Retraction
Published on 26 Apr 2023
Retraction: The role of LINC00284 in the development of thyroid cancer via its regulation of the microRNA-30d-5p-mediated ADAM12/Notch axis
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1209909
- 1,063 views
Editorial
Published on 26 Apr 2023
Editorial: Host-pathogen interactions interplay and cancer: understanding mechanisms and beyond
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1202004
- 977 views
Original Research
Published on 26 Apr 2023
Impact of microvessel patterns and immune status in NSCLC: a non-angiogenic vasculature is an independent negative prognostic factor in lung adenocarcinoma
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1157461
- 1,839 views
- 4 citations
Original Research
Published on 25 Apr 2023
Virtual screening of ultra-large chemical libraries identifies cell-permeable small-molecule inhibitors of a “non-druggable” target, STAT3 N-terminal domain
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1144153
- 3,013 views
- 8 citations
Original Research
Published on 24 Apr 2023
miRNome of Child A hepatocellular carcinoma in Egyptian patients
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1137585
- 1,924 views
Review
Published on 24 Apr 2023
Cancer-associated fibroblasts in gynecological malignancies: are they really allies of the enemy?
in Molecular and Cellular Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1106757
- 2,352 views
- 2 citations